Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Erythromycins from Taisho for Gram-positive infections

July 22, 1998

RiboGene receives additional funding in the area of antifungals

July 21, 1998

Antifungal series emerges from R&D at Pola

July 21, 1998

Potent, broad-spectrum antibacterial compounds developed at Daiichi

July 21, 1998

NeXstar initiates third phase II MiKasome trial

July 21, 1998

Sankyo presents new antifungal agents for Candida infections

July 20, 1998

Antibacterial agent of microbial origin discovered by Sankyo

July 20, 1998

Pola discloses new antifungal agents

July 17, 1998

Locally applied fusafungine for rhinitis and sinusitis

July 17, 1998

Cephalosporins described by Roche for Gram-positive infections

July 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...